Federal Register Notice: FDA and the University of Maryland Center for Excellence in Regulatory Science and Innovation will co-sponsor a public workshop 5/4 entitled “Methodological Considerations to Address Unmeasured Information About Important Health Factors in Pharmacoepidemiology Studies that Rely on Electronic Healthcare Databases to Evaluate the Safety of Regulated Pharmaceutical Products in the Postapproval Setting.” The workshop will be held from, 8 a.m. to 5 p.m. at the FDA White Oak Campus, 10903 New Hampshire Ave., Bldg. 31 Conference Center, the Great Room (Rm. 1503), Silver Spring, MD. Contact Leslie Wheelock, (301) 796-4580, leslie.wheelock@fda.hhs.gov. To view this notice, click here.